{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T11:16:44Z","timestamp":1784546204605,"version":"3.55.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Oncol Rep"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1007\/s11912-018-0664-3","type":"journal-article","created":{"date-parts":[[2018,3,2]],"date-time":"2018-03-02T12:05:49Z","timestamp":1519992349000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Updates on Gallbladder Cancer Management"],"prefix":"10.1007","volume":"20","author":[{"given":"Mohammad Yahya","family":"Zaidi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shishir K.","family":"Maithel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,3,2]]},"reference":[{"issue":"1","key":"664_CR1","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.jamcollsurg.2010.09.009","volume":"212","author":"JM Butte","year":"2011","unstructured":"Butte JM, Matsuo K, G\u00f6nen M, D\u2019Angelica MI, Waugh E, Allen PJ, et al. Gallbladder cancer: differences in presentation, surgical treatment, and survival in patients treated at centers in three countries. J Am Coll Surg. 2011;212(1):50\u201361. https:\/\/doi.org\/10.1016\/j.jamcollsurg.2010.09.009 .","journal-title":"J Am Coll Surg"},{"issue":"7","key":"664_CR2","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1002\/jso.21141","volume":"98","author":"A Duffy","year":"2008","unstructured":"Duffy A, Capanu M, Abou-Alfa GK, Huitzil D, Jarnagin W, Fong Y, et al. Gallbladder cancer (GBC): 10-year experience at memorial Sloan-Kettering cancer Centre (MSKCC). J Surg Oncol. 2008;98(7):485\u20139. https:\/\/doi.org\/10.1002\/jso.21141 .","journal-title":"J Surg Oncol"},{"issue":"3","key":"664_CR3","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.ejso.2007.07.206","volume":"34","author":"G Miller","year":"2008","unstructured":"Miller G, Jarnagin WR. Gallbladder carcinoma. Eur J Surg Oncol. 2008 Mar;34(3):306\u201312. https:\/\/doi.org\/10.1016\/j.ejso.2007.07.206 .","journal-title":"Eur J Surg Oncol"},{"issue":"12","key":"664_CR4","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1002\/bjs.1800831215","volume":"83","author":"VK Kapoor","year":"1996","unstructured":"Kapoor VK, Pradeep R, Haribhakti SP, Singh V, Sikora SS, Saxena R, et al. Intrahepatic segment III cholangiojejunostomy in advanced carcinoma of the gallbladder. Br J Surg. 1996;83(12):1709\u201311. https:\/\/doi.org\/10.1002\/bjs.1800831215 .","journal-title":"Br J Surg"},{"issue":"14","key":"664_CR5","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1056\/NEJMoa0908721","volume":"362","author":"J Valle","year":"2010","unstructured":"Valle J, Wasan H, Palmer DH, Cunningham D, Anthoney A, Maraveyas A, et al. Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. N Engl J Med. 2010;362(14):1273\u201381. https:\/\/doi.org\/10.1056\/NEJMoa0908721 .","journal-title":"N Engl J Med"},{"issue":"2","key":"664_CR6","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1093\/annonc\/mdt540","volume":"25","author":"JW Valle","year":"2014","unstructured":"Valle JW, Furuse J, Jitlal M, Beare S, Mizuno N, Wasan H, et al. Cisplatin and gemcitabine for advanced biliary tract cancer: a meta-analysis of two randomised trials. Ann Oncol. 2014;25(2):391\u20138. https:\/\/doi.org\/10.1093\/annonc\/mdt540 .","journal-title":"Ann Oncol"},{"issue":"6","key":"664_CR7","doi-asserted-by":"publisher","first-page":"996","DOI":"10.21037\/jgo.2016.09.10","volume":"7","author":"R Agarwal","year":"2016","unstructured":"Agarwal R, Sendilnathan A, Siddiqi NI, Gulati S, Ghose A, Xie C, et al. Advanced biliary tract cancer: clinical outcomes with ABC-02 regimen and analysis of prognostic factors in a tertiary care center in the United States. J Gastrointest Oncol. 2016;7(6):996\u20131003. https:\/\/doi.org\/10.21037\/jgo.2016.09.10 .","journal-title":"J Gastrointest Oncol"},{"issue":"6","key":"664_CR8","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1093\/jjco\/hyt059","volume":"43","author":"R Kameda","year":"2013","unstructured":"Kameda R, Ando T, Kobayashi S, Ueno M, Ohkawa S. A retrospective study of chemotherapy with cisplatin plus gemcitabine after the failure of gemcitabine monotherapy for biliary tract cancer. Jpn J Clin Oncol. 2013 Jun;43(6):636\u201340. https:\/\/doi.org\/10.1093\/jjco\/hyt059 .","journal-title":"Jpn J Clin Oncol"},{"issue":"5","key":"664_CR9","first-page":"1783","volume":"29","author":"Z Morise","year":"2009","unstructured":"Morise Z, Sugioka A, Tanahashi Y, Okabe Y, Ikeda M, Kagawa T, et al. Treatment of patients with unresectable advanced carcinoma of biliary tract\u2014chemotherapy and surgical resection. Anticancer Res. 2009;29(5):1783\u20136.","journal-title":"Anticancer Res"},{"issue":"4C","key":"664_CR10","first-page":"2373","volume":"28","author":"S Ina","year":"2008","unstructured":"Ina S, Tani M, Kawai M, Hirono S, Miyazawa M, Nishioka R, et al. Phase 2 trial of oral S-1 combined with low-dose cisplatin for unresectable advanced pancreatic cancer. Anticancer Res. 2008;28(4C):2373\u20137.","journal-title":"Anticancer Res"},{"key":"664_CR11","unstructured":"AJCC. Cancer Staging Manual. 8th ed. 2017."},{"issue":"71","key":"664_CR12","first-page":"660","volume":"53","author":"A Principe","year":"2006","unstructured":"Principe A, Del Gaudio M, Ercolani G, Golfieri R, Cucchetti A, Pinna AD. Radical surgery for gallbladder carcinoma: possibilities of survival. Hepato-Gastroenterology. 2006;53(71):660\u20134.","journal-title":"Hepato-Gastroenterology"},{"issue":"11","key":"664_CR13","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1007\/s11605-007-0309-6","volume":"11","author":"TM Pawlik","year":"2007","unstructured":"Pawlik TM, Gleisner AL, Vigano L, Kooby DA, Bauer TW, Frilling A, et al. Incidence of finding residual disease for incidental gallbladder carcinoma: implications for re-resection. J Gastrointest Surg. 2007;11(11):1478\u201386; discussion 1486-7. https:\/\/doi.org\/10.1007\/s11605-007-0309-6 .","journal-title":"J Gastrointest Surg"},{"issue":"3","key":"664_CR14","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.jamcollsurg.2014.01.069","volume":"219","author":"JM Butte","year":"2014","unstructured":"Butte JM, Kingham TP, G\u00f6nen M, D\u2019Angelica MI, Allen PJ, Fong Y, et al. Residual disease predicts outcomes after definitive resection for incidental gallbladder cancer. J Am Coll Surg. 2014 Sep;219(3):416\u201329. https:\/\/doi.org\/10.1016\/j.jamcollsurg.2014.01.069 .","journal-title":"J Am Coll Surg"},{"issue":"8","key":"664_CR15","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1111\/hpb.12444","volume":"17","author":"TA Aloia","year":"2015","unstructured":"\u2022 Aloia TA, J\u00e1rufe N, Javle M, Maithel SK, Roa JC, Adsay V, et al. Gallbladder cancer: expert consensus statement. HPB (Oxford). 2015;17(8):681\u201390. https:\/\/doi.org\/10.1111\/hpb.12444 . This is a recently published consensus statement on the management of gallbladder cancer across multiple disciplines addressing current standards of care and areas of controversy.","journal-title":"HPB (Oxford)"},{"issue":"5","key":"664_CR16","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1245\/s10434-016-5637-x","volume":"24","author":"CG Ethun","year":"2017","unstructured":"\u2022 Ethun CG, Postlewait LM, Le N, Pawlik TM, Buettner S, Poultsides G, et al. A novel pathology-based preoperative risk score to predict locoregional residual and distant disease and survival for incidental gallbladder cancer: a 10-institution study from the U.S. extrahepatic biliary malignancy consortium. Ann Surg Oncol. 2017;24(5):1343\u201350. https:\/\/doi.org\/10.1245\/s10434-016-5637-x . This study represents one of several studies published from a recent multi-institutional biliary malignancy collaborative analyzing clinicopathologic variables and outcomes.","journal-title":"Ann Surg Oncol"},{"issue":"7","key":"664_CR17","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1111\/j.1477-2574.2011.00325.x","volume":"13","author":"JM Butte","year":"2011","unstructured":"Butte JM, G\u00f6nen M, Allen PJ, D\u2019Angelica MI, Kingham TP, Fong Y, et al. The role of laparoscopic staging in patients with incidental gallbladder cancer. HPB (Oxford). 2011;13(7):463\u201372. https:\/\/doi.org\/10.1111\/j.1477-2574.2011.00325 .","journal-title":"HPB (Oxford)"},{"issue":"4","key":"664_CR18","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1002\/bjs.9025","volume":"100","author":"L Vigan\u00f2","year":"2013","unstructured":"Vigan\u00f2 L, Ferrero A, Amisano M, Russolillo N, Capussotti L. Comparison of laparoscopic and open intraoperative ultrasonography for staging liver tumours. Br J Surg. 2013;100(4):535\u201319. https:\/\/doi.org\/10.1002\/bjs.9025 .","journal-title":"Br J Surg"},{"issue":"4","key":"664_CR19","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1245\/s10434-008-0189-3","volume":"16","author":"M D\u2019Angelica","year":"2009","unstructured":"D\u2019Angelica M, Dalal KM, DeMatteo RP, Fong Y, Blumgart LH, Jarnagin WR. Analysis of the extent of resection for adenocarcinoma of the gallbladder. Ann Surg Oncol. 2009;16(4):806\u201316. https:\/\/doi.org\/10.1245\/s10434-008-0189-3 .","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"664_CR20","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1245\/s10434-009-0319-6","volume":"16","author":"TM Pawlik","year":"2009","unstructured":"Pawlik TM, Choti MA. Biology dictates prognosis following resection of gallbladder carcinoma: sometimes less is more. Ann Surg Oncol. 2009;16(4):787\u20138. https:\/\/doi.org\/10.1245\/s10434-009-0319-6 .","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"664_CR21","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1097\/01.sla.0000154118.07704.ef","volume":"241","author":"E Dixon","year":"2005","unstructured":"Dixon E, Vollmer CM Jr, Sahajpal A, Cattral M, Grant D, Doig C, et al. An aggressive surgical approach leads to improved survival in patients with gallbladder cancer: a 12-year study at a North American Center. Ann Surg. 2005;241(3):385\u201394. https:\/\/doi.org\/10.1097\/01.sla.0000154118.07704.ef .","journal-title":"Ann Surg"},{"issue":"2","key":"664_CR22","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1002\/jso.24283","volume":"114","author":"F Gani","year":"2016","unstructured":"Gani F, Buettner S, Margonis GA, Ethun CG, Poultsides G, Tran T, et al. Assessing the impact of common bile duct resection in the surgical management of gallbladder cancer. J Surg Oncol. 2016;114(2):176\u201380. https:\/\/doi.org\/10.1002\/jso.24283 .","journal-title":"J Surg Oncol"},{"issue":"2","key":"664_CR23","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1097\/SLA.0b013e31822238d8","volume":"254","author":"H Ito","year":"2011","unstructured":"Ito H, Ito K, D\u2019Angelica M, Gonen M, Klimstra D, Allen P, et al. Accurate staging for gallbladder cancer: implications for surgical therapy and pathological assessment. Ann Surg. 2011;254(2):320\u20135. https:\/\/doi.org\/10.1097\/SLA.0b013e31822238d8 .","journal-title":"Ann Surg"},{"issue":"6","key":"664_CR24","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1007\/s005340100022","volume":"8","author":"V Paolucci","year":"2001","unstructured":"Paolucci V. Port site recurrences after laparoscopic cholecystectomy. J Hepato-Biliary-Pancreat Surg. 2001;8(6):535\u201343. Review. https:\/\/doi.org\/10.1007\/s005340100022 .","journal-title":"J Hepato-Biliary-Pancreat Surg"},{"issue":"1","key":"664_CR25","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1053\/ejso.2001.1175","volume":"28","author":"S Varshney","year":"2002","unstructured":"Varshney S, Butturini G, Gupta R. Incidental carcinoma of the gallbladder. Eur J Surg Oncol. 2002;28(1):4\u201310. Review. Erratum in: Eur J Surg Oncol. 2006 Nov;32(9):II. Buttirini, G [corrected to Butturini, G]. https:\/\/doi.org\/10.1053\/ejso.2001.1175 .","journal-title":"Eur J Surg Oncol"},{"issue":"3","key":"664_CR26","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1007\/s12262-012-0592-7","volume":"74","author":"S Rathanaswamy","year":"2012","unstructured":"Rathanaswamy S, Misra S, Kumar V, Chintamani PJ, Agarwal A, Gupta S. Incidentally detected gallbladder cancer- the controversies and algorithmic approach to management. Indian J Surg. 2012;74(3):248\u201354. https:\/\/doi.org\/10.1007\/s12262-012-0592-7 .","journal-title":"Indian J Surg"},{"issue":"2","key":"664_CR27","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1245\/s10434-011-1850-9","volume":"19","author":"AV Maker","year":"2012","unstructured":"Maker AV, Butte JM, Oxenberg J, Kuk D, Gonen M, Fong Y, et al. Is port site resection necessary in the surgical management of gallbladder cancer? Ann Surg Oncol. 2012;19(2):409\u201317. https:\/\/doi.org\/10.1245\/s10434-011-1850-9 .","journal-title":"Ann Surg Oncol"},{"issue":"7","key":"664_CR28","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1002\/jso.24591","volume":"115","author":"CG Ethun","year":"2017","unstructured":"Ethun CG, Postlewait LM, Le N, Pawlik TM, Poultsides G, Tran T, et al. Routine port-site excision in incidentally discovered gallbladder cancer is not associated with improved survival: a multi-institution analysis from the US Extrahepatic Biliary Malignancy Consortium. J Surg Oncol. 2017;115(7):805\u201311. https:\/\/doi.org\/10.1002\/jso.24591 .","journal-title":"J Surg Oncol"},{"issue":"4","key":"664_CR29","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.jviscsurg.2013.03.006","volume":"150","author":"D Fuks","year":"2013","unstructured":"Fuks D, Regimbeau JM, Pessaux P, Bachellier P, Raventos A, Mantion G, et al. Is port-site resection necessary in the surgical management of gallbladder cancer? J Visc Surg. 2013;150(4):277\u201384. https:\/\/doi.org\/10.1016\/j.jviscsurg.2013.03.006 .","journal-title":"J Visc Surg"},{"issue":"10","key":"664_CR30","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1177\/000313481508101005","volume":"81","author":"GL Chen","year":"2015","unstructured":"Chen GL, Akmal Y, DiFronzo AL, Vuong B, O\u2019Connor V. Porcelain gallbladder: no longer an indication for prophylactic cholecystectomy. Am Surg. 2015;81(10):936\u201340.","journal-title":"Am Surg"},{"issue":"4","key":"664_CR31","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1007\/s00423-015-1302-2","volume":"400","author":"BI Babu","year":"2015","unstructured":"Babu BI, Dennison AR, Garcea G. Management and diagnosis of gallbladder polyps: a systematic review. Langenbeck\u2019s Arch Surg. 2015;400(4):455\u201362. https:\/\/doi.org\/10.1007\/s00423-015-1302-2 .","journal-title":"Langenbeck\u2019s Arch Surg"},{"issue":"3","key":"664_CR32","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1245\/ASO.2004.03.011","volume":"11","author":"WG Hawkins","year":"2004","unstructured":"Hawkins WG, DeMatteo RP, Jarnagin WR, Ben-Porat L, Blumgart LH, Fong Y. Jaundice predicts advanced disease and early mortality in patients with gallbladder cancer. Ann Surg Oncol. 2004;11(3):310\u20135. https:\/\/doi.org\/10.1245\/ASO.2004.03.011 .","journal-title":"Ann Surg Oncol"},{"issue":"8","key":"664_CR33","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1007\/s11605-017-3440-z","volume":"21","author":"TB Tran","year":"2017","unstructured":"Tran TB, Norton JA, Ethun CG, Pawlik TM, Buettner S, Schmidt C, et al. Gallbladder cancer presenting with jaundice: uniformly fatal or still potentially curable? J Gastrointest Surg. 2017;21(8):1245\u201353. https:\/\/doi.org\/10.1007\/s11605-017-3440-z .","journal-title":"J Gastrointest Surg"},{"issue":"8","key":"664_CR34","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1002\/cncr.11699","volume":"98","author":"WR Jarnagin","year":"2003","unstructured":"Jarnagin WR, Ruo L, Little SA, Klimstra D, D\u2019Angelica M, DeMatteo RP, et al. Patterns of initial disease recurrence after resection of gallbladder carcinoma and hilar cholangiocarcinoma: implications for adjuvant therapeutic strategies. Cancer. 2003;98(8):1689\u2013700. https:\/\/doi.org\/10.1002\/cncr.11699 .","journal-title":"Cancer"},{"issue":"4","key":"664_CR35","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1007\/s11605-009-1140-z","volume":"14","author":"WS Kim","year":"2010","unstructured":"Kim WS, Choi DW, You DD, Ho CY, Heo JS, Choi SH. Risk factors influencing recurrence, patterns of recurrence, and the efficacy of adjuvant therapy after radical resection for gallbladder carcinoma. J Gastrointest Surg. 2010;14(4):679\u201387. https:\/\/doi.org\/10.1007\/s11605-009-1140-z .","journal-title":"J Gastrointest Surg"},{"issue":"11","key":"664_CR36","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1016\/j.hpb.2016.05.016","volume":"18","author":"GA Margonis","year":"2016","unstructured":"Margonis GA, Gani F, Buettner S, Amini N, Sasaki K, Andreatos N, et al. Rates and patterns of recurrence after curative intent resection for gallbladder cancer: a multi-institution analysis from the US Extra-hepatic Biliary Malignancy Consortium. HPB. 2016;18(11):872\u20138. https:\/\/doi.org\/10.1016\/j.hpb.2016.05.016 .","journal-title":"HPB"},{"issue":"10","key":"664_CR37","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1007\/s11605-010-1335-3","volume":"14","author":"SC Mayo","year":"2010","unstructured":"Mayo SC, Shore AD, Nathan H, Edil B, Wolfgang CL, Hirose K, et al. National trends in the management and survival of surgically managed gallbladder adenocarcinoma over 15 years: a population-based analysis. J Gastrointest Surg. 2010;14(10):1578\u201391. https:\/\/doi.org\/10.1007\/s11605-010-1335-3 .","journal-title":"J Gastrointest Surg"},{"issue":"8","key":"664_CR38","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1002\/cncr.10831","volume":"95","author":"T Takada","year":"2002","unstructured":"Takada T, Amano H, Yasuda H, Nimura Y, Matsushiro T, Kato H, et al. Study group of surgical adjuvant therapy for carcinomas of the pancreas and biliary tract. Is postoperative adjuvant chemotherapy useful for gallbladder carcinoma? A phase III multicenter prospective randomized controlled trial in patients with resected pancreaticobiliary carcinoma. Cancer. 2002;95(8):1685\u201395. https:\/\/doi.org\/10.1002\/cncr.10831 .","journal-title":"Cancer"},{"issue":"1","key":"664_CR39","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1186\/s12885-015-1617-y","volume":"15","author":"N Ma","year":"2015","unstructured":"Ma N, Cheng H, Qin B, Zhong R, Wang B. Adjuvant therapy in the treatment of gallbladder cancer: a meta-analysis. BMC Cancer. 2015;15(1):615. https:\/\/doi.org\/10.1186\/s12885-015-1617-y .","journal-title":"BMC Cancer"},{"issue":"Suppl 4","key":"664_CR40","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1200\/JCO.2017.35.4_suppl.225","volume":"35","author":"J Edelin","year":"2017","unstructured":"Edelin J, et al. Gemox versus surveillance following surgery of localized biliary tract cancer: results of the PRODIGE 12-ACCORD 18 (UNICANCER GI) phase III trial. J Clin Oncol. 2017;35(Suppl 4):225. https:\/\/doi.org\/10.1200\/JCO.2017.35.4_suppl.225 .","journal-title":"J Clin Oncol"},{"key":"664_CR41","doi-asserted-by":"crossref","unstructured":"\u2022 Primrose JN. et al. Adjuvant capecitabine for biliary tract cancer: The BILCAP randomized study. J Clin Oncol. 2017;35(Suppl 15): 4006-4006. This is a recently reported phase III randomized control trial of patients treated with adjuvant capecitabine demonstrating an improvement in median OS and RFS compared to observation alone.","DOI":"10.1200\/JCO.2017.35.15_suppl.4006"},{"issue":"Suppl 3","key":"664_CR42","doi-asserted-by":"publisher","first-page":"S1100","DOI":"10.1245\/s10434-015-4685-y","volume":"22","author":"J Wang","year":"2015","unstructured":"Wang J, Narang AK, Sugar EA, Luber B, Rosati LM, Hsu CC, et al. Evaluation of adjuvant radiation therapy for resected gallbladder carcinoma: a multi-institutional experience. Ann Surg Oncol. 2015;22(Suppl 3):S1100\u20136. https:\/\/doi.org\/10.1245\/s10434-015-4685-y .","journal-title":"Ann Surg Oncol"}],"container-title":["Current Oncology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11912-018-0664-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11912-018-0664-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11912-018-0664-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,28]],"date-time":"2020-10-28T22:46:40Z","timestamp":1603925200000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11912-018-0664-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":42,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["664"],"URL":"https:\/\/doi.org\/10.1007\/s11912-018-0664-3","relation":{},"ISSN":["1523-3790","1534-6269"],"issn-type":[{"value":"1523-3790","type":"print"},{"value":"1534-6269","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"2 March 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Mohammad Yahya Zaidi and Shishir K. Maithel declare they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}],"article-number":"21"}}